Correll Jesse T.

Insider Reports History

Signature
/s/ Jill Martin, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Correll Jesse T.:

Form 4 holding Chairman & CEO, Director, 10%+ Owner

UTG INC

Security class
Common Stock
Shares / value
1,201,876
Estimated value
$69,107,870
Report date
18 May 2026
Price
$57.50
Ownership
By First Southern Holdings, LLC.
Form 4 holding Chairman & CEO, Director, 10%+ Owner

UTG INC

Security class
Common Stock
Shares / value
491,807
Estimated value
$27,029,712
Report date
18 May 2026
Price
$54.96
Ownership
By First Southern Funding, LLC
Form 4 holding Chairman & CEO, Director, 10%+ Owner

UTG INC

Security class
Common Stock
Shares / value
204,909
Estimated value
$11,782,267
Report date
18 May 2026
Price
$57.50
Ownership
By First Southern Bancorp, Inc.
Form 4 holding Chairman & CEO, Director, 10%+ Owner

UTG INC

Security class
Common Stock
Shares / value
81,562
Estimated value
$4,689,815
Report date
18 May 2026
Price
$57.50
Ownership
Direct
Form 4 holding Chairman & CEO, Director, 10%+ Owner

UTG INC

Security class
Common Stock
Shares / value
72,750
Estimated value
$4,183,125
Report date
18 May 2026
Price
$57.50
Ownership
By WCorrell, Limited Partnership
Form 4 holding Chairman & CEO, Director, 10%+ Owner

UTG INC

Security class
Stock Options
Shares / value
15,000
Estimated value
$862,500
Report date
18 May 2026
Price
$57.50
Ownership
Direct
Underlying class
Common Stock
Underlying amount
15,000

Insider Reports Filed by Correll Jesse T.

4 UTGN

UTG INC

Report period
18 May 2026
Transactions
1
Transaction value
+$266,556
Filing time
20 May 2026, 15:25
Role
Chairman & CEO, Director, 10%+ Owner
Next action
Open filing details
4 UTGN

UTG INC

Report period
06 May 2025
Transactions
1
Transaction value
+$3,478,280
Filing time
08 May 2025, 14:47
Role
Chairman & CEO, Director, 10%+ Owner
Next action
Open filing details
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .